Endothelin A receptor drugs for Pulmonary Arterial Hypertension

2 tracked Endothelin A receptor drugs in the Pulmonary Arterial Hypertension race. The class explanation lives on the Endothelin A receptor page; the full indication pipeline across every mechanism is on the Pulmonary Arterial Hypertension page.

1 approved / phase 41 preclinical / unstaged

Head-to-head evidence: Ambrisentan vs F230

The roster

← all Endothelin A receptor drugs